We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Les toxicités cardiovasculaires des traitements oncologiques.
- Authors
Kalou, K.; Zelek, L.
- Abstract
Until recent years, cardiac toxicity mainly occurred during chemotherapy with anthracyclines or fluorouracile. Recent advances including protective agents or liposomal formulations contributed to circumvent drug-induced heart failure. Yet, we are now faced with an expanding burden of unexpected toxicities due to the growing use of targeted therapies, mainly trastuzumab, but also, in a lesser extent, antiangiogenic therapies.
- Subjects
TOXICOLOGY; DRUG therapy; ANTHRACYCLINES; FLUOROURACIL; HEART failure; TRASTUZUMAB
- Publication
Oncologie (Tech Science Press), 2006, Vol 8, Issue 10, p901
- ISSN
1292-3818
- Publication type
Article
- DOI
10.1007/s10269-006-0558-0